ReviewMedicina (Kaunas, Lithuania)2019
Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion.
Review in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Evaluating PERFAMLI and CHA₂DS₂-VASc scoring systems in predicting left atrial thrombosis in non-valvular atrial fibrillation.Journal of cardiothoracic surgery · 2026Article
- Coronary Angiography Detecting Left Atrial Appendage Thrombus.Internal medicine (Tokyo, Japan) · 2026Article
- Thromboembolism in the left atrial appendage under atrial fibrillation and after sinus rhythm restoration: a computational study.Frontiers in bioengineering and biotechnology · 2026Article
- Article
- Article
- Article
- Review
- Left atrial appendage thrombus in an elderly patient with atrial fibrillation during non-cardiac surgery- a case report.BMC anesthesiology · 2023Article
- Massive Mysteries.The American journal of cardiology · 2023Article
- Mechanical concordance between left atrium and left atrial appendage in nonvalvular atrial fibrillation: can it be exploited to avoid transesophageal echocardiography prior to electrical cardioversion during Covid-19 pandemic?The international journal of cardiovascular imaging · 2022Article
- Proposal for a clinical and an echocardiographic score for prediction of left atrial thrombosis in atrial fibrillation patients undergoing early electrical cardioversion.International journal of clinical practice · 2021Article
- A rare sighting: left atrial appendage thrombus seen on transthoracic echocardiogram.Journal of geriatric cardiology : JGC · 2021Article
- Device related thrombosis after left atrial appendage occlusion: does thrombus location always predicts its origin?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke and thromboembolic complications. A rhythm control strategy with both electrical and pharmacological cardioversion is recommended for patients with symptomatic atrial fibrillation. Anticoagulant therapy for 3-4 weeks prior to cardioversion is recommended in order to avoid thromboembolic events deriving from restoring sinus rhythm. Transesophageal echocardiography has a pivotal role in this setting, excluding the presence of left atrial appendage thrombus before cardioversion. The aim of this review is to discuss the epidemiology and risk factors for left atrial appendage thrombosis, the role of echocardiography in the decision making before cardioversion, and the efficacy of different anticoagulant regimens on the detection and treatment of left atrial appendage thrombosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.